# Breast cancer incidence and mortality before and after implementation of the German mammography screening program


## Artificial Intelligence


### Health


#### Breast Cancer

<p><details><summary>Q: Provide the numbers showing the seriousness of breast cancer in Germany.</summary><b>Answer</b>: <ul data-original-markdown="LSBCcmVhc3QgY2FuY2VyIChCQykgaXMgdGhlIG1vc3QgY29tbW9uIGNhbmNlciBhbmQgdGhlIG1vc3QgY29tbW9uIGNhbmNlci1yZWxhdGVkIGNhdXNlIG9mIGRlYXRoIGluIHdvbWVuIGluIEdlcm1hbnkuIDxiciAvPi0gSW4gMjAxOCwgYWJvdXQgNzIsMDAwIGluY2lkZW50IGNhc2VzIHdlcmUgZXhwZWN0ZWQgYW5kIGFib3V0IDE5LDAwMCB3b21lbiBkaWVkIGZyb20gQkMgaW4gMjAxNi4=">
<li>Breast cancer (BC) is the most common cancer and the most common cancer-related cause of death in women in Germany. </li>
<li>In 2018, about 72,000 incident cases were expected and about 19,000 women died from BC in 2016.</li>
</ul>

</details></p>

<p><details><summary>Q: What do the authors conclude?</summary><b>Answer</b>: <ul data-original-markdown="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">
<li>The observed reduction of late-stage breast cancer incidence in the screening exposed age group in Germany is most likely to be attributed to the introduction of the national mammography screening program.</li>
<li>In addition, the observed reduction of disease-specific mortality fits the expected pattern, but the proportion to which the mammography screening contributed to the reduction is unclear.</li>
<li>These positive effects are bought at the cost of a moderate occurrence of overdiagnosis, especially by a sharp increase of in situ cancers.</li>
</ul>

</details></p>

<p><details><summary>Q: Summarize the history of the German mammography screening program.</summary><b>Answer</b>: <ul data-original-markdown="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">
<li>To reduce the burden of BC in Germany a public debate about the implementation of an organized mammography screening started in the 1990s. </li>
<li>Initial pilot projects were implemented in 2001. </li>
<li>In 2002, the German parliament decided to introduce an organized, population-based national breast cancer screening program for women aged 50â€“69 years. </li>
<li>In 2005, the rollout of the screening program, which is strictly following the European guidelines on breast cancer screening (EUREF), started and was completely implemented nation-wide until 2009. </li>
<li>Key features of the program are: 94 mammography units (each covering a population of about 500,000 to 1 million), a centralized population-based invitation system, invitation every 2 years with a proposal of time and place for the examination, independent double reading of mammograms, high level quality assurance by reference centers and a national evaluation unit with yearly benchmarking. </li>
<li>Today almost 100% of German women aged 50 to 69 years are invited to the mammography screening every 2 years, and participation rate is about 50% since the year 2009.</li>
</ul>

</details></p>

